Article
Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin.
International journal of medical sciences - 1 Jan 2016
Kanda Tatsuo, Nakamoto Shingo, Sasaki Reina, Nakamura Masato, Yasui Shin, Haga Yuki, Ogasawara Sadahisa, Tawada Akinobu, Arai Makoto, Mikami Shigeru, Imazeki Fumio, Yokosuka Osamu
Abstract excerpt
BACKGROUND: Direct-acting antiviral agents against HCV with or without peginterferon plus ribavirin result in higher eradication rates of HCV and shorter treatment duration. We examined which is better for predicting persistent virologic response, the assessment of serum HCV RNA at 12 or 24 weeks after the end of treatment for predicting sustained virologic response (SVR12 or SVR24, respectively) in patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.